Intrinsic Value of S&P & Nasdaq Contact Us

ClearPoint Neuro, Inc. CLPT NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.00
+73.4%

Stock Statistics — CLPT

ClearPoint Neuro, Inc. (CLPT) has a market capitalization of $308.79M and trades at $10.38. The 52-week range is 8.6-30.1.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -11.5, Earnings Per Share (EPS) of $-0.90, annual revenue of $36.97M.

The stock has a beta of 1.18, operates in the Healthcare sector.

Trading Data
Current Price$10.38
52-Week Range8.6-30.1
Volume408.12K
Avg Volume (30D)806.98K
Market Cap$308.79M
Beta (1Y)1.18
Company
IPO Date2012-05-22
Employees115
CEOJoseph Michael Burnett
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS18507C1036
CUSIP18507C103
Income (Latest Year)
Revenue$36.97M
Gross Profit$22.69M
EBITDA$-21.93M
Operating Income$-24.16M
Net Income$-25.54M
EPS$-0.90
EPS Diluted$-0.90
Shares Outstanding$28.32M
Balance Sheet (Latest Year)
Total Assets$97.75M
Current Assets$63.6M
Cash & ST Investments$45.92M
Total Liabilities$69.73M
Total Debt$58.23M
Net Debt$12.31M
Total Equity$28.02M
Debt / Equity2.08
Valuation Ratios
P/E Ratio-11.5
P/S Ratio8.35
P/B Ratio11.02
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message